|By PR Newswire||
|February 11, 2014 06:49 PM EST||
NEW YORK, Feb. 11, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NanoViricides, Inc. ("NanoViricides" or the "Company")(NYSE MKT: NNVC). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 237.
The investigation concerns whether NanoViricides and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On Tuesday, February 11, 2014, a report was published on Seekingalpha.com website questioning the integrity of the company and its officers. The article in part stated that, "NNVC shareholders seem unaware of [an] incriminating must-read document, written by a company insider and supporter, which outlines countless examples and allegations of NNVC managers Seymour and Diwan abusing shareholders and looting the company."
On this news, shares fell $1.42 per share to $3.00 or more than 32.13%, on February 11, 2014.
The Pomerantz Firm, with offices in New York, Chicago, San Diego and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
Robert S. Willoughby
SOURCE Pomerantz LLP